An expert panel has concluded that more research is needed before circulating tumor DNA analyses are adopted in clinical care. This finding may slow the use of such testing among oncologists, some of whom are already basing treatment decisions on the results of these assays.
from Cancer via ola Kala on Inoreader https://ift.tt/2jnY3hb
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου